Connection

STEVEN SCHERER to Mutation

This is a "connection" page, showing publications STEVEN SCHERER has written about Mutation.
Connection Strength

1.905
  1. A recessive Trim2 mutation causes an axonal neuropathy in mice. Neurobiol Dis. 2020 07; 140:104845.
    View in: PubMed
    Score: 0.241
  2. A dominant connexin43 mutant does not have dominant effects on gap junction coupling in astrocytes. Neuron Glia Biol. 2010 Nov; 6(4):213-23.
    View in: PubMed
    Score: 0.129
  3. A novel recessive Nefl mutation causes a severe, early-onset axonal neuropathy. Ann Neurol. 2009 Dec; 66(6):759-70.
    View in: PubMed
    Score: 0.118
  4. The effects of a dominant connexin32 mutant in myelinating Schwann cells. Mol Cell Neurosci. 2006 Jul; 32(3):283-98.
    View in: PubMed
    Score: 0.093
  5. Charcot-Marie-Tooth disease and related neuropathies. Nat Rev Dis Primers. 2026 Jan 22; 12(1):3.
    View in: PubMed
    Score: 0.090
  6. Genotype and phenotype spectrum of Charcot-Marie-Tooth disease due to mutations in SORD. Brain. 2025 Oct 03; 148(10):3737-3747.
    View in: PubMed
    Score: 0.088
  7. Prenylation-defective human connexin32 mutants are normally localized and function equivalently to wild-type connexin32 in myelinating Schwann cells. J Neurosci. 2005 Aug 03; 25(31):7111-20.
    View in: PubMed
    Score: 0.087
  8. Disease mechanisms in inherited neuropathies. Nat Rev Neurosci. 2003 Sep; 4(9):714-26.
    View in: PubMed
    Score: 0.076
  9. Axonal Charcot-Marie-Tooth Disease: from Common Pathogenic Mechanisms to Emerging Treatment Opportunities. Neurotherapeutics. 2021 10; 18(4):2269-2285.
    View in: PubMed
    Score: 0.067
  10. A recurrent MORC2 mutation causes Charcot-Marie-Tooth disease type 2Z. J Peripher Nerv Syst. 2021 06; 26(2):184-186.
    View in: PubMed
    Score: 0.065
  11. POLG mutations presenting as Charcot-Marie-Tooth disease. J Peripher Nerv Syst. 2019 06; 24(2):213-218.
    View in: PubMed
    Score: 0.056
  12. A novel MFN2 mutation causes variable clinical severity in a multi-generational CMT2 family. Neuromuscul Disord. 2019 02; 29(2):134-137.
    View in: PubMed
    Score: 0.055
  13. Myelinated axons fail to develop properly in a genetically authentic mouse model of Charcot-Marie-Tooth disease type 2E. Exp Neurol. 2018 10; 308:13-25.
    View in: PubMed
    Score: 0.053
  14. Mutations in ATP1A1 Cause Dominant Charcot-Marie-Tooth Type 2. Am J Hum Genet. 2018 03 01; 102(3):505-514.
    View in: PubMed
    Score: 0.052
  15. Rare Variants in MME, Encoding Metalloprotease Neprilysin, Are Linked to Late-Onset Autosomal-Dominant Axonal Polyneuropathies. Am J Hum Genet. 2016 09 01; 99(3):607-623.
    View in: PubMed
    Score: 0.047
  16. Target-enrichment sequencing and copy number evaluation in inherited polyneuropathy. Neurology. 2016 05 10; 86(19):1762-71.
    View in: PubMed
    Score: 0.046
  17. A novel AARS mutation in a family with dominant myeloneuropathy. Neurology. 2015 May 19; 84(20):2040-7.
    View in: PubMed
    Score: 0.043
  18. A new mutation in GJC2 associated with subclinical leukodystrophy. J Neurol. 2014 Oct; 261(10):1929-38.
    View in: PubMed
    Score: 0.041
  19. Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain. 2014 Jan; 137(Pt 1):44-56.
    View in: PubMed
    Score: 0.039
  20. Prediction of cochlear implant performance by genetic mutation: the spiral ganglion hypothesis. Hear Res. 2012 Oct; 292(1-2):51-8.
    View in: PubMed
    Score: 0.036
  21. Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations. Brain. 2009 Feb; 132(Pt 2):426-38.
    View in: PubMed
    Score: 0.027
  22. Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008 Oct 23; 455(7216):1069-75.
    View in: PubMed
    Score: 0.027
  23. MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Hum Mol Genet. 2007 Oct 15; 16(20):2453-62.
    View in: PubMed
    Score: 0.025
  24. T118M PMP22 mutation causes partial loss of function and HNPP-like neuropathy. Ann Neurol. 2006 Feb; 59(2):358-64.
    View in: PubMed
    Score: 0.023
  25. Disease Progression in Charcot-Marie-Tooth Disease Type 4B (CMT4B) Associated With Mutations in Myotubularin-Related Proteins 2 and 13. Eur J Neurol. 2025 Feb; 32(2):e70084.
    View in: PubMed
    Score: 0.021
  26. The genomic and evolutionary landscapes of anaplastic thyroid carcinoma. Cell Rep. 2024 03 26; 43(3):113826.
    View in: PubMed
    Score: 0.020
  27. Genetic analysis and natural history of Charcot-Marie-Tooth disease CMTX1 due to GJB1 variants. Brain. 2023 10 03; 146(10):4336-4349.
    View in: PubMed
    Score: 0.019
  28. Neuropathy due to bi-allelic SH3TC2 variants: genotype-phenotype correlation and natural history. Brain. 2023 09 01; 146(9):3826-3835.
    View in: PubMed
    Score: 0.019
  29. Knock-in mouse models for CMTX1 show a loss of function phenotype in the peripheral nervous system. Exp Neurol. 2023 02; 360:114277.
    View in: PubMed
    Score: 0.018
  30. Disease Progression in Charcot-Marie-Tooth Disease Related to MPZ Mutations: A Longitudinal Study. Ann Neurol. 2023 03; 93(3):563-576.
    View in: PubMed
    Score: 0.018
  31. HINT1 neuropathy in Lithuania: clinical, genetic, and functional profiling. Orphanet J Rare Dis. 2022 10 14; 17(1):374.
    View in: PubMed
    Score: 0.018
  32. Variants in genes coding for collagen type IV a-chains are frequent causes of persistent, isolated hematuria during childhood. Pediatr Nephrol. 2023 03; 38(3):687-695.
    View in: PubMed
    Score: 0.018
  33. TUBB4A mutations result in both glial and neuronal degeneration in an H-ABC leukodystrophy mouse model. Elife. 2020 05 28; 9.
    View in: PubMed
    Score: 0.015
  34. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet. 1999 Aug; 22(4):336-45.
    View in: PubMed
    Score: 0.014
  35. Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis. Cell Rep. 2019 02 19; 26(8):2241-2256.e4.
    View in: PubMed
    Score: 0.014
  36. Cross-sectional analysis of a large cohort with X-linked Charcot-Marie-Tooth disease (CMTX1). Neurology. 2017 Aug 29; 89(9):927-935.
    View in: PubMed
    Score: 0.013
  37. De novo PMP2 mutations in families with type 1 Charcot-Marie-Tooth disease. Brain. 2016 06; 139(Pt 6):1649-56.
    View in: PubMed
    Score: 0.011
  38. CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis. J Neurol Neurosurg Psychiatry. 2015 Aug; 86(8):873-8.
    View in: PubMed
    Score: 0.010
  39. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science. 1993 Dec 24; 262(5142):2039-42.
    View in: PubMed
    Score: 0.010
  40. Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor. Gastroenterology. 2013 Nov; 145(5):1098-1109.e1.
    View in: PubMed
    Score: 0.009
  41. Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer. Genome Res. 2012 Nov; 22(11):2120-9.
    View in: PubMed
    Score: 0.009
  42. High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability. Cancer Discov. 2011 Jul; 1(2):170-85.
    View in: PubMed
    Score: 0.008
  43. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet. 2009 May; 84(5):617-27.
    View in: PubMed
    Score: 0.007
  44. Reversion of a promoter deletion in yeast. Nature. 1982 Aug 26; 298(5877):815-9.
    View in: PubMed
    Score: 0.004
  45. Notch1 control of oligodendrocyte differentiation in the spinal cord. J Cell Biol. 2002 Aug 19; 158(4):709-18.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.